Controversies in the treatment of advanced ovarian cancer in the PARP inhibitors era: a Delphi consensus.

Through the methodology used, a consensus was reached in approximately half of the statements. The results of this work may be useful in addressing the most controversial issues on the management of advanced ovarian cancer.